A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- Sponsors Astellas Pharma US
- 22 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
- 01 Oct 2005 New trial record.